TrialBMC nephrology2018

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).

Tomoko Horinouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.